Manufacturer
Acer Therapeutics
- Products listed
- 5
- Molecules
- 2
- Therapy areas
- 2
Acer Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 5 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Acer Therapeutics Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Acer Therapeutics products through licensed channels, with the documents your regulator needs.
Neurology
4 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Miplyffa 124 mg capsuleOral | Arimoclomol | US FDA | Available on request |
| Miplyffa 47 mg capsuleOral | Arimoclomol | US FDA | Available on request |
| Miplyffa 62 mg capsuleOral | Arimoclomol | US FDA | Available on request |
| Miplyffa 93 mg capsuleOral | Arimoclomol | US FDA | Available on request |
Rare diseases and enzyme replacement
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Olpruva kitOral | Sodium phenylbutyrate | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Acer Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.